Gear Isle Issues Voluntary Nationwide Recall of Pro Power Knight Plus, NUX Male Enhancement and DYNAMITE SUPER Capsules Due to the Presence of Sildenafil and Tadalafil
West Sacramento, CA, Gear Isle is voluntarily recalling the following products listed in the table below to the consumer level. FDA analysis has found the products to be tainted with sildenafil and tadalafil. Sildenafil and tadalafil are ingredients known as Phosphodiesterase Inhibitors (PDE-5) inhi (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Johnson & Johnson Reports Q1 2023 Results
New Brunswick, N.J. (April 18, 2023) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2023. “Our first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. “With this momentum, I look forward to the remainder of the year, one filled with exciting catalysts that will create both near- and long-term value for patients and all of our stakeholders.”OVERALL FINANCIAL RESULTSQ1($ in Millions, except EPS)2...
Source: Johnson and Johnson - April 18, 2023 Category: Pharmaceuticals Tags: Financial Source Type: news
Fixed-Dose Combo Pill for PAH Promises Accelerated Benefit: A DUE Fixed-Dose Combo Pill for PAH Promises Accelerated Benefit: A DUE
According to a randomized trial, macitentan and tadalafil are safe and effective in a fixed-dose combination even as first-line therapy. The results of the three-arm study were presented at ACC 2023.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 10, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Late-Breaking Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Hemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, March 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 A DUE study (NCT03904693), which showed an investigational once-daily, single tablet combination therapy, also known as fixed dose combination, of macitentan 10 mg and tadalafil 40 mg (M/T STCT), significantly improved pulmonary hemodynamics (blood flow through pulmonary blood vessels) versus macitentan and tadalafil monotherapies in pulmonary arterial hypertension (PAH) patients with World Health Organization (WHO) functional class (FC) II or III.[1] The data were presented today as a Late-...
Source: Johnson and Johnson - March 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Volt Candy Issues Voluntary Nationwide Recall of PrimeZen Black 6000 Capsules Due to Presence of Sildenafil and Tadalafil
Pomona, California, Volt Candy is voluntarily recalling one lot of PrimeZen Black 6000, 2000 mg capsule, to the consumer level. FDA analysis has found PrimeZen Black 6000 capsules to be tainted with sildenafil& tadalafil. Sildenafil and tadalafil are phosphodiesterase (PDE-5) inhibitors found in FD (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 14, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Hims & Hers debuts chewables for erectile dysfunction
The “Hard Mints” product will be offered in a variety of dosages; variations can include vardenafil, tadalafil, and sildenafil (the same active ingredients as in Levitra, Cialis, and Viagra, respectively). Rolling out Tuesday, they’ll start at $30 per month and will be available in the entire U.S.…#hardmints #levitra #cialis #viagra #peterstahl #apostrophe #honesthealth #spac #himshershealth #hims (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2023 Category: Consumer Health News Source Type: news
Study: Viagra, Cialis Users 25% Less Likely To Suffer Early Death, Here Are Caveats
Those taking such erectile dysfunction medications also had a 17% lower incidence of heart failure, a 15% lower incidence of getting a coronary revascularization procedure, a 22% lower incidence of unstable angina, and a 39% lower incidence of death from cardiovascular causes. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 21, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
Viagra, Cialis, and Alzheimer's Risk: New Data Viagra, Cialis, and Alzheimer's Risk: New Data
Contrary to earlier findings, new research shows there is no impact of erectile dysfunction on Alzheimer ' s or dementia risk.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 27, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
No association of Viagra and Cialis with reduced Alzheimer ’s disease risk
Researchers found no evidence that the drugs Viagra and Cialis reduce the risk of Alzheimer ’s and related dementias. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - October 17, 2022 Category: Consumer Health News Source Type: news
Can Erectile Dysfunction Drugs Reduce Dementia Risk?
(MedPage Today) -- New research failed to support the hypothesis that phosphodiesterase-5 (PDE5) inhibitors like sildenafil (Viagra) and tadalafil (Cialis) are promising drug repurposing candidates for Alzheimer's disease and dementia.
Using four... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 4, 2022 Category: Psychiatry Source Type: news
NIH DREAM study finds Viagra and Cialis do not reduce risk of Alzheimer ’s and related dementias
Researchers tested phosphodiesterase-5 inhibitors, which work by relaxing smooth muscle cells. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - October 4, 2022 Category: American Health Source Type: news
Proper Trade LLC/My Stellar Lifestyle Issues Voluntary Nationwide Recall of Wonder Pill Capsules Due to the Presence of Undeclared Tadalafil
Proper Trade LLC/My Stellar Lifestyle is voluntarily recalling Wonder Pill lot 20210912 and lot 31853-501 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 28, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Warns 4 Companies For Hidden Erectile Dysfunction Medications In Honey-Based Products
Oh honey. Did someone put some tadalafil or sildenafil in the honey-based product that you are taking without telling you? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Lifestyle /lifestyle Vices /vices business pharma Source Type: news
Ultra Supplement LLC Issues Voluntary Nationwide Recall of Sustango Due to the Presence of Undeclared Tadalafil
Wilmington DE, Ultra Supplement LLC is voluntarily recalling lot number DAP272109, exp 4/1/26 of Sustango capsules packaged in 10-count blisters packaged in a carton to the consumer level. Ultra Supplement was notified by Amazon that laboratory analysis has found the product to be tainted with tadal (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
MKS Enterprise LLC Voluntary Recalls of Dose Vital VIP Vital Honey Due to Presence of Undeclared Tadalafil
This product was found to contain the undeclared active pharmaceutical ingredient tadalafil. Tadalafil, which is a phosphodiesterase type-5 (PDE-5) inhibitor, is the active ingredient in an FDA-approved prescription drug, used to treat erectile dysfunction (ED). This undeclared ingredient may intera (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 19, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
